Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Gene translocations in musculoskeletal neoplasms Krishnan B; Khanna G; Clohisy DClin Orthop Relat Res 2008[Sep]; 466 (9): 2131-46Establishing the best diagnosis for musculoskeletal neoplasms requires a multidisciplinary approach using clinical, radiographic, and histologic analyses. Despite this rigorous approach, establishing accurate diagnoses and prognoses remains challenging. Improved diagnostic methods are expected as unique molecular signals for specific bone and soft tissue cancers are identified. We performed a systematic review of the best available evidence to explore three major applications of molecular genetics that will best benefit clinical management of musculoskeletal neoplasms: diagnostic, prognostic, and therapeutic applications. The specific questions addressed in this systematic review are: (1) What sets of histopathologic sarcoma subtypes will benefit from molecular evaluation and diagnosis? (2) What molecular methods are best applied to histopathologic sarcomas to distinguish between major subtypes? (3) How do the molecular patterns discovered on genetic diagnosis affect prognosis of certain sarcomas? (4) Which sarcoma translocations can benefit from an improved response and outcome using existing and forthcoming pharmacogenetic approaches targeting molecular events? This review summarizes recent advances in molecular genetics that are available and will soon be available to clinicians to better predict outcomes and subsequently help make future treatment decisions. LEVEL OF EVIDENCE: Level IV, diagnostic study. See the Guidelines for Authors for a complete description of levels of evidence.|Algorithms[MESH]|Bone Neoplasms/*genetics/pathology[MESH]|Humans[MESH]|Immunochemistry[MESH]|Karyotyping[MESH]|Muscle Neoplasms/*genetics/pathology[MESH]|Oncogene Proteins, Fusion/genetics[MESH]|Prognosis[MESH]|RNA-Binding Protein EWS/genetics[MESH]|RNA-Binding Protein FUS/genetics[MESH]|Reverse Transcriptase Polymerase Chain Reaction[MESH]|Sarcoma/genetics/pathology[MESH]|Signal Transduction/genetics[MESH]|Transcription Factor CHOP/genetics[MESH]|Translocation, Genetic[MESH] |
